Description
Recombinant monoclonal antibody to IGFBP7. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the llama peripheral blood lymphocytes 4.43. This chimeric mouse antibody was made using the variable domain sequences of the original Llama VHH format, for improved compatibility with existing reagents, assays and techniques.
Target
IGFBP7
Target Alias Names
IBP-7, IGFBP-7, MAC25, PSF, IGFBP-rP1, MAC25 protein, TAF, IGF-binding protein 7, Insulin-like growth factor-binding protein 7, PGI2-stimulating factor, Prostacyclin-stimulating factor, Tumor-derived adhesion factor, angiomodulin
Isotype/Mimetic
IgG1-Fc Fusion
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression